Corpus Intelligence IC Memo — OCEANS BEHAVIORAL HOSPITAL BILOXI 2026-04-26 13:28 UTC
IC Memo — OCEANS BEHAVIORAL HOSPITAL BILOXI
Investment Committee Memorandum | MS | 45 beds | Grade C | EBITDA uplift $1.0M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

OCEANS BEHAVIORAL HOSPITAL BILOXI

CCN 254012 | nan, MS | 45 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

OCEANS BEHAVIORAL HOSPITAL BILOXI is a 45-bed safety-net/medicaid heavy in nan, MS with $13.6M in net patient revenue and a 18.8% operating margin. The hospital serves a payer mix of 21.5% Medicare, 31.1% Medicaid, and 47.4% commercial.

Thesis: Turnaround. Our ML models identify $1.0M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 18.8% to 26.1% (+737bps).

Net Revenue HCRIS$13.6M
Current EBITDA COMPUTED$2.6M
Operating Margin COMPUTED18.8%
Occupancy HCRIS74.3%
Revenue / Bed COMPUTED$303K
Net-to-Gross HCRIS55.7%
Distress Probability ML53.0%

2. Market Context & Competitive Position

110
MS Hospitals
-12.5%
State Median Margin
62
Comparable Hospitals

MS has 110 Medicare-certified hospitals with a median operating margin of -12.5%. The target's margin of 18.8% places it above the state median. Among 62 size-comparable peers (22-90 beds), the median margin is -13.9%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (22-90), prioritizing same-state peers. 62 hospitals in the comp set.

HospitalStateBedsRevenueMargin
OCEANS BEHAVIORAL HOSPITAL BIL (Target)MS45$13.6M18.8%
BAPTIST MEM HOSPITAL UNION COUMS83$117.9M3.7%
METHODIST H/C OLIVE BRANCH HOSMS65$75.4M-25.6%
NORTH SUNFLOWER COUNTY HOSPITAMS25$70.1M-7.2%
MISSISSIPPI METHODIST REHAB CEMS31$68.1M-0.5%
UMMC-GRENADAMS49$63.7M7.1%
OKTIBBEHA COUNTY HOSPITALMS88$63.2M-16.5%
NESHOBA COUNTY GENERAL HOSPITAMS38$47.6M-19.7%
ALLIANCE HEALTH CENTERMS79$46.1M32.5%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.0M (737bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$287K+210bp18mo
Cost to Collect4.5%2.5%$273K+200bp12mo
Denial Rate Reduction12.0%6.5%$271K+199bp12mo
A/R Days Reduction5200.0%3800.0%$166K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+7bp6mo

5. EBITDA Bridge

Net Collection Rate
$287K
Cost to Collect
$273K
Denial Rate Reduction
$271K
A/R Days Reduction
$166K
Clean Claim Rate
$10K
Total EBITDA Uplift$1.0M
Current EBITDA$2.6M
+ RCM Uplift+$1.0M
Pro Forma EBITDA$3.6M
Current Margin18.8%
Pro Forma Margin26.1%
WC Released (1x)$523K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$3.9M$27.0M6.84x46.9%
Base (11x exit)10.0x11.0x$3.9M$30.9M7.85x51.0%
Bull Case9.0x11.0x$3.5M$35.5M10.02x58.6%
Bull (12x exit)9.0x12.0x$3.5M$39.8M11.23x62.2%
Bear Case11.0x10.0x$4.3M$20.6M4.76x36.6%
Bear (11x exit)11.0x11.0x$4.3M$24.1M5.56x41.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumElevated Medicaid exposure (31.1%)Medicaid reimburses below cost in most states. Mitigant: denial reduction lever has highest impact on Medicaid claims
HighElevated distress probabilityModel estimates 53.0% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 62 hospitals with 22-90 beds
  • Same-state prioritization (n=63)
  • Comp margins: P25=-22.4% / P50=-13.9% / P75=-0.5%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.